We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PHUN:NASDAQPhunware, Inc. Analysis

Data as of 2026-05-22 - not real-time

$2.02

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Phunware (PHUN) trades at $2.02, sitting just above the computed support of $1.88 and below resistance at $2.30. The 20‑day SMA (2.10) sits above the 50‑day SMA (1.98) but both remain under the 200‑day SMA (2.19), indicating short‑term bullish bias within a longer‑term downtrend. Momentum is neutral with an RSI of 48 and a bearish MACD histogram (-0.018), while volume is increasing, suggesting renewed trader interest. The stock’s beta of 2.48 and a 30‑day volatility of ~59% point to pronounced price swings, and the historical max drawdown of -57% underscores the downside risk. Fundamentally, revenue fell 21% YoY, margins are deeply negative (operating margin -7.4%), and both operating and free cash flow are in the -$10M to -$13M range. However, the company holds $97.9M in cash against modest debt ($0.5M) and trades at a price‑to‑book of 0.44, implying a significant discount to its book value. No dividend is paid, and earnings per share remain negative. Recent material news highlights a leadership transition with Dmitry Kroshka as CEO, the launch of an AI‑enabled “2.0” platform targeting hospitality, and a Q1 loss of $3.2 M. These developments could catalyze top‑line growth but remain unproven.
Overall, PHUN appears undervalued on a balance‑sheet basis yet faces substantial execution risk. Technical indicators are mixed to bearish, and the high beta amplifies downside potential. The strategic pivot to AI and new product rollouts provide a possible growth catalyst, but the company must reverse its cash‑flow negativity and improve profitability to justify a higher valuation.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD histogram and RSI near neutral
  • Proximity to technical support level
  • Increasing volume indicating potential short‑term buying interest

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • New AI‑enabled platform and leadership change could drive revenue growth
  • Strong cash position relative to debt
  • Undervalued price‑to‑book ratio offering margin of safety

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Persistent negative cash flow and earnings
  • High beta and volatility increasing downside risk
  • Uncertain timeline for commercial adoption of new products

Key Metrics & Analysis

Financial Health

Revenue Growth-21.20%
P/E Ratio-3.9
ROE-11.04%
ROA-11.65%
Debt/Equity0.58
P/B Ratio0.4
Op. Cash Flow$-11859000
Free Cash Flow$-13130375
Industry P/E39.1

Technical Analysis

TrendNeutral
RSI48.0
Support$1.88
Resistance$2.30
MA 20$2.10
MA 50$1.98
MA 200$2.19
MACDBearish
VolumeIncreasing
Fear & Greed Index91.5

Valuation

Target Price$2.00
Upside/Downside-0.99%
GradeUndervalued
TypeBlend

Risk Assessment

Beta2.48
Volatility59.48%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.